| (+)-Dehydroisoandrosterone |
| (1S,2R,5S,10R,11S,15S)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-14-one |
| (1S,2R,5S,10R,11S,15S)-5-HYDROXY-2,15-DIMETHYLTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADEC-7-EN-14-ONE |
| (1S,5S,11S,15S,2R,10R)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0<2,7>.0<11,15> ]heptadec-7-en-14-one |
| (3-beta)-3-Hydroxyandrost-5-en-17-one |
| (3beta)-3-hydroxyandrost-5-en-17-one |
| (3beta)-3-Hydroxyandrost-5-ene-17-one |
| (3S,8R,9S,10R,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,10,11,12,13,14,15,16-tetradecahydro-17H-cyclopenta[a]phenanthren-17-one |
| (3S,8R,9S,10R,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one |
| (3S,8R,9S,10R,13S,14S)-3-hydroxy-10,13-dimethyl-3,4,7,8,9,10,11,12,13,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17(2H)-one |
| 105597-37-3 |
| 108673-53-6 |
| 17-Chetovis |
| 17-Hormoforin |
| 1A9D2040-240C-427D-ADE4-0CB700B785CB |
| 3-|A-hydroxy-5-androsten-17-one |
| 3-beta-hydroxy-5-androsten-17-on |
| 3-beta-Hydroxy-5-androsten-17-one |
| 3-beta-hydroxyandrost-5-en-17-one |
| 3.beta.-Hydroxyandrost-5-en-17-one |
| 3beta-hydroxy-5-androsten-17-one |
| 3beta-Hydroxy-D5-androsten-17-one |
| 3beta-hydroxyandrost-5-en-17-one |
| 3beta-Hydroxyandrost-5-ene-17-one |
| 3beta-Hyroxyandrost-5-en-17-one |
| 4-08-00-00994 (Beilstein Handbook Reference) |
| 459AG36T1B |
| 5-Androsten-3.beta.-ol-17-one |
| 5-Androsten-3beta-ol-17-one |
| 5-Androsten-3beta-ol-17-one; DHEA |
| 5-Dehydroepiandrosterone |
| 5,6-Dehydroisoandrosterone |
| 5,6-Dehydroisoandrostorone |
| 5,6-didehydroepiandrosterone |
| 5,6-Didehydroisoandrosterone |
| 53-43-0 |
| 9013-35-8 |
| AB0007943 |
| AB00375810_09 |
| AB00375810-06 |
| AB1009532 |
| AC-28716 |
| AC1L1LC4 |
| ACT02646 |
| AJ-45664 |
| AK125048 |
| AKOS007930299 |
| AKOS015951378 |
| AN-24410 |
| Anastar |
| AND |
| Andrestenol |
| Androst-5-en-17-one, 3-beta-hydroxy- |
| Androst-5-en-17-one, 3-hydroxy-, (3-beta)- |
| Androst-5-en-17-one, 3-hydroxy-, (3-beta)- (9CI) |
| Androst-5-en-17-one, 3-hydroxy-, (3.beta.)- |
| Androst-5-en-17-one, 3-hydroxy-, (3b)- |
| Androst-5-en-17-one, 3-hydroxy-, (3beta)- |
| Androst-5-en-17-one, 3-hydroxy-, (3beta)- (9CI) |
| Androst-5-en-17-one, 3.beta.-hydroxy- |
| Androst-5-en-17-one, 3beta-hydroxy- |
| Androst-5-en-17-one, 3beta-hydroxy- (8CI) |
| Androst-5-ene-3beta-ol-17-one |
| Androstenolone |
| Aslera |
| Astenile |
| BCP9000602 |
| BCPE00002 |
| BCPP000260 |
| BDBM50223368 |
| BIDD:PXR0080 |
| Biolaif (TN) |
| bmse000665 |
| BRN 2058110 |
| C-18147 |
| C01227 |
| CAS-53-43-0 |
| Caswell No. 051F |
| CC-26313 |
| CCG-101190 |
| CCRIS 3277 |
| CHEBI:28689 |
| CHEMBL90593 |
| CMC_13435 |
| CS-1667 |
| D 4000 |
| D-0340 |
| D0044 |
| D00OAW |
| D08409 |
| D0K0EK |
| D5-Androsten-3beta-ol-17-one |
| DB01708 |
| Deandros |
| Dehydro-epi-androsterone |
| dehydroepiandrostenedione |
| Dehydroepiandrosternoe |
| Dehydroepiandrosterone |
| dehydroepiandrosterone (dhea) |
| Dehydroepiandrosterone, Neuroscience Pharma |
| Dehydroepiandrosterone, Paladin Labs |
| Dehydroisoandrosterone |
| Delta5-androsten-3-beta-ol-17-one |
| DHEA |
| DHEA (trans-Dehydroandrosterone) |
| DHEA, Neuroscience Pharma |
| DHEA, Paladin Labs |
| Diandron |
| Diandrone |
| DL-373 |
| DSSTox_CID_379 |
| DSSTox_GSID_20379 |
| DSSTox_RID_75553 |
| DTXSID4020379 |
| EBD1328208 |
| EC 200-175-5 |
| EINECS 200-175-5 |
| EL-10 |
| EM-760 |
| EPA Pesticide Chemical Code 126510 |
| Epiandrosterone, 5-dehydro- |
| EU-0100368 |
| Fidelin |
| Fidelin T |
| FMGSKLZLMKYGDP-USOAJAOKSA-N |
| GL 701 |
| GL-701 |
| GL701 |
| GS-0906 |
| GTPL2370 |
| HMS2052P11 |
| HMS2090C04 |
| HMS2232K11 |
| HY-14650 |
| Hydroxyandrost-5-en-17-one |
| IM 28 |
| Inflabloc |
| Intrarosa |
| IP-1001 |
| IPL-1001 |
| J10065 |
| LMST02020021 |
| Lopac0_000368 |
| LS-7296 |
| M-1336 |
| MFCD00003613 |
| MLS001066350 |
| MLS001333231 |
| MLS001333232 |
| MLS001424274 |
| MolPort-003-929-763 |
| NC00440 |
| NCGC00093802-04 |
| NCGC00093802-06 |
| NCGC00256412-01 |
| NCGC00259545-01 |
| NCI60_042215 |
| NSC 9896 |
| NSC-9896 |
| NSC9896 |
| PB-007 |
| PL000184 |
| Prasterona |
| Prasterona [INN-Spanish] |
| Prasterone (DHEA; Dehydroepiandrosterone) |
| Prasterone (DHEA; Dehydroepiandrosterone) 1.0 mg/ml in Acetonitrile |
| Prasterone (INN) |
| Prasterone [INN] |
| Prasterone [USAN:INN] |
| Prasteronum |
| Prasteronum [INN-Latin] |
| Prestara |
| Psicosterone |
| s2604 |
| SBB012501 |
| SCHEMBL24156 |
| SH-K-04828 |
| Siscelar plus |
| SMR000059075 |
| SR-01000075815 |
| SR-01000075815-1 |
| ST069381 |
| Tox21_111222 |
| Tox21_111222_1 |
| Tox21_201996 |
| Tox21_302761 |
| TR-018899 |
| trans-de-hydroandrosterone |
| trans-Dehydroandrosterone |
| trans-Dehydroandrosterone, >=99% |
| UNII-459AG36T1B |
| Vaginorm |
| Z2213891300 |
| ZINC3807917 |
